STONY BROOK, N.Y. – August 9, 2022 – Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in polymerase chain reaction (“PCR”)-based technologies, today announced that The City University of New York (CUNY), the largest urban university in the United States, has extended its health services contract for COVID-19 testing [...]
By Ken Schachter | September 2, 2021 A Stony Brook company whose human COVID-19 vaccine was repurposed to treat cats has pivoted to a more promising animal market: mink farms. Applied DNA Sciences Inc. expects to begin the new animal trials in upstate Brewster this month, a company spokesman said. Mink, however, will [...]
Background Mutations are the norm for viruses, especially RNA viruses like SARS-CoV-2. SARS-CoV-2 has been mutating throughout the pandemic. Recently a deletion mutation in the S-gene of SARS-CoV-2 has emerged. The mutation is a 6-nucleotide deletion (21765-21770) within the S-gene that results in the deletion of two [...]
Program to Support Weekly Testing of Up to 9,000 Faculty and Staff at Peak Operations, Equates to Use of Approximately 1,800 Tests per Week; Applied DNA Receives Initial Stocking Order Under Master Services Agreement STONY BROOK, N.Y. – November 10, 2020 - Applied DNA Sciences, Inc., (NASDAQ: APDN) (“Applied [...]
Small businesses and community groups have been particularly hard hit by COVID-19, both financially and in the availability and continuity of their essential staff. We have been conducting daily COVID-19 pooled surveillance testing for one such cohort of approximately 25 individuals of a 3-generational family plus friends, neighbors and household [...]
The FDA SARS-CoV-2 Reference Panel allows for a more precise comparison of the analytical performance of different molecular in vitro diagnostic (IVD) assays intended to detect SARS-CoV-2. The Reference Panel contains common, independent, and well-characterized reference material that is available to developers of SARS-CoV-2 nucleic acid-based amplification tests (NAATs) for which Emergency Use Authorization (EUA) [...]